1. Knowledge Gaps and Educational Needs Among Patients Receiving Long-Acting Injectable Cabotegravir/Rilpivirine: A Multisite Cross-Sectional Survey
    Olivia Youngblood et al. · AIDS Patient Care and STDs · 2026
  2. Kaposi Sarcoma and HHV-8-Associated Multicentric Castleman Disease: A Case Report
    Kari Shad et al. · DigitalCommons@UNMC · 2026
  3. No “other” way: modification of urinalysis-driven reflex urine culture protocol to reduce inpatient urine cultures
    Mackenzie Rae Keintz et al. · Infection Control and Hospital Epidemiology · 2026
  4. HPV vaccine series completion in a midwestern HIV/PrEP population
    Kathleen Nguyen et al. · AIDS Care · 2026
  5. Missed opportunities for HIV prevention: Low linkage to follow-up care after emergency department initiation of nonoccupational postexposure prophylaxis
    Kathleen Nguyen et al. · The American Journal of Emergency Medicine · 2026
  6. Are SEP-1 and blood culture stewardship at odds? Retrospective review of SEP-1 failures pre- and during a blood culture bottle shortage – ADDENDUM
    Jonathan H. Ryder et al. · Infection Control and Hospital Epidemiology · 2026
  7. Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience
    Joshua P Havens et al. · Clinical Infectious Diseases · 2026
  8. Determinants of staff-perceived feasibility for long-acting injectable antiretroviral therapy implementation for patients with HIV in rural and non-metropolitan areas
    Emmanuel Nazaire Essam Nkodo et al. · BMC Health Services Research · 2026
  9. How place, trust, and care location influence rural and non-metropolitan patients’ preferences for decentralized long-acting injectable HIV therapy: A mixed-methods study
    Emmanuel Nazaire Essam Nkodo et al. · BMC Health Services Research · 2026
  10. Emergence of Integrase Strand Transfer Inhibitor Resistance Following Treatment of Latent Tuberculosis Infection in a Patient With HIV
    Emily Dyer et al. · Open Forum Infectious Diseases · 2026